Figure 5

mHSP/P+Cy+IL12 vaccination elicits a tumor-specific CTL response. The cytolysis percent of mHSP/P+Cy+IL12 vaccine is significantly higher than mHSP/P vaccine and naïve mice *P < 0.05, and tumor bearing mice, #P < 0.01.